Literature DB >> 26228407

Development of a clinician-administered National Institutes of Health-Brief Fatigue Inventory: A measure of fatigue in the context of depressive disorders.

Leorey N Saligan1, David A Luckenbaugh2, Elizabeth E Slonena2, Rodrigo Machado-Vieira2, Carlos A Zarate2.   

Abstract

OBJECTIVE: Fatigue is a complex, multidimensional condition. Although it is often associated with depression, it is not known whether it has a distinct network from depression or whether it can be clinically evaluated, separately. This study describes preliminary findings in the development of a brief, clinician-administered instrument to measure fatigue in the context of depressive disorders using items from existing clinician-administered depression and mania scales.
METHODS: Based on items from prior fatigue measurements, items were selected from the Hamilton Depression Rating Scale (HDRS), Montgomery-Asberg Depression Rating Scale (MADRS), Young Mania Rating Scale, and Structured Interview Guide for HDRS with Atypical Depression. The final items composed the NIH-Brief Fatigue Inventory (NIH-BFI). Responses from 89 depressed adults collected pre- and post-antidepressant therapy (ADT) determined the reliability and consistency of the NIH-BFI using Cronbach's alpha and principal components analysis (PCA). Correlations of the NIH-BFI and fatigue items from other scales before and after ADT explored validity.
RESULTS: The 7-item NIH-BFI had Cronbach alphas ranging from 0.81 to 0.88 and PCA indicating a single dimension. The NIH-BFI score was strongly correlated (r = 0.73, p < 0.001) with fatigue items from Beck Depression Index, with MADRS without fatigue items (r = 0.77, p < 0.001), and HDRS without fatigue items (pre: r = 0.69, p < 0.001).
CONCLUSIONS: Preliminary findings show support for internal consistency reliability and validity of the NIH-BFI, a clinician-administered measure of fatigue. Further testing in other clinical populations is recommended to obtain additional information on reliability and validity. The NIH-BFI provides a method for clinician-rated fatigue that may be a separate from depression. Published by Elsevier Ltd.

Entities:  

Keywords:  Clinician-administered scale; Depression; Fatigue; Instrument development

Mesh:

Year:  2015        PMID: 26228407      PMCID: PMC4522041          DOI: 10.1016/j.jpsychires.2015.06.012

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  49 in total

1.  Reliability and validity of the Massachusetts general hospital cognitive and physical functioning questionnaire.

Authors:  Maurizio Fava; Dan V Iosifescu; Paola Pedrelli; Lee Baer
Journal:  Psychother Psychosom       Date:  2009-02-13       Impact factor: 17.659

2.  Low-Dose Ketamine Infusion for Emergency Department Patients with Severe Pain.

Authors:  Terence L Ahern; Andrew A Herring; Steve Miller; Bradley W Frazee
Journal:  Pain Med       Date:  2015-02-03       Impact factor: 3.750

3.  Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern.

Authors:  D C Kroencke; S G Lynch; D R Denney
Journal:  Mult Scler       Date:  2000-04       Impact factor: 6.312

4.  Differential expression of genes related to mitochondrial biogenesis and bioenergetics in fatigued prostate cancer men receiving external beam radiation therapy.

Authors:  Chao-Pin Hsiao; Dan Wang; Aradhana Kaushal; Mei-Kuang Chen; Leorey Saligan
Journal:  J Pain Symptom Manage       Date:  2014-04-28       Impact factor: 3.612

5.  Fatigue in multiple sclerosis and its relationship to depression and neurologic disability.

Authors:  R Bakshi; Z A Shaikh; R S Miletich; D Czarnecki; J Dmochowski; K Henschel; V Janardhan; N Dubey; P R Kinkel
Journal:  Mult Scler       Date:  2000-06       Impact factor: 6.312

6.  The Fatigue Questionnaire: Standardization in patients with major depression.

Authors:  Panagiotis Ferentinos; Vassilis Kontaxakis; Beata Havaki-Kontaxaki; Dimitris Dikeos; George Papadimitriou
Journal:  Psychiatry Res       Date:  2010-04-09       Impact factor: 3.222

7.  Relationship of cortical atrophy to fatigue in patients with multiple sclerosis.

Authors:  Clelia Pellicano; Antonio Gallo; Xiaobai Li; Vasiliki N Ikonomidou; Iordanis E Evangelou; Joan M Ohayon; Susan K Stern; Mary Ehrmantraut; Fredric Cantor; Henry F McFarland; Francesca Bagnato
Journal:  Arch Neurol       Date:  2010-04

8.  Self- and clinician-rated Montgomery-Asberg Depression Rating Scale: evaluation in clinical practice.

Authors:  G Bondolfi; F Jermann; B Weber Rouget; M Gex-Fabry; A McQuillan; A Dupont-Willemin; J-M Aubry; C Nguyen
Journal:  J Affect Disord       Date:  2009-08-05       Impact factor: 4.839

Review 9.  Fatigue in chronic disease.

Authors:  M G Swain
Journal:  Clin Sci (Lond)       Date:  2000-07       Impact factor: 6.124

Review 10.  Cancer-related fatigue and its associations with depression and anxiety: a systematic review.

Authors:  Linda F Brown; Kurt Kroenke
Journal:  Psychosomatics       Date:  2009 Sep-Oct       Impact factor: 2.386

View more
  5 in total

1.  A systematic review of the association between fatigue and cognition in chronic noncommunicable diseases.

Authors:  Victoria Menzies; Debra L Kelly; Gee S Yang; Angela Starkweather; Debra E Lyon
Journal:  Chronic Illn       Date:  2019-03-18

2.  Disentangling the association of depression on the anti-fatigue effects of ketamine.

Authors:  Leorey N Saligan; Cristan Farmer; Elizabeth D Ballard; Bashkim Kadriu; Carlos A Zarate
Journal:  J Affect Disord       Date:  2018-10-06       Impact factor: 4.839

3.  An assessment of the anti-fatigue effects of ketamine from a double-blind, placebo-controlled, crossover study in bipolar disorder.

Authors:  Leorey N Saligan; David A Luckenbaugh; Elizabeth E Slonena; Rodrigo Machado-Vieira; Carlos A Zarate
Journal:  J Affect Disord       Date:  2016-01-19       Impact factor: 4.839

Review 4.  Fatigue in Patients with Major Depressive Disorder: Prevalence, Burden and Pharmacological Approaches to Management.

Authors:  Helia Ghanean; Amanda K Ceniti; Sidney H Kennedy
Journal:  CNS Drugs       Date:  2018-01       Impact factor: 5.749

5.  Moxibustion at 'Danzhong' (RN17) and 'Guanyuan' (RN4) for fatigue symptom in patients with depression: Study protocol clinical trial (SPIRIT Compliant).

Authors:  Somayeh Iravani; Liwei Cai; Lue Ha; Shuzhe Zhou; Chuan Shi; Yibin Ma; Qin Yao; Ke Xu; Baixiao Zhao
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.